Alkali-controlled one-pot synthesis of ultrasmall pegylated polydopamine nanoparticles for diverse biological applications

Key Points

• To create a universal platform using ultrasmall pegylated polydopamine nanoparticles for disease diagnosis and treatment.
• Developed a one-pot synthesis approach using alkali control.
• Synthesized ultrasmall pegylated polydopamine nanoparticles (UPPDA NPs).
• UPPDA NPs show potential for various diagnostic applications.
• Demonstrated effectiveness in treatment strategies.